#USA #Pittsburgh #Infection Control #UPMC Hospital #Genomic Surveillance

UPMC Presbyterian Hospital Receives Joint Commission Award

UPMC Presbyterian Hospital, located in Pittsburgh, has recently garnered significant recognition from the Joint Commission for its groundbreaking work in genomic surveillance aimed at enhancing patient safety and quality of care. The hospital has been awarded the John M. Eisenberg Local Innovation in Patient Safety and Quality Award, a testament to its pioneering efforts in utilizing bacterial whole genome sequencing (WGS) to detect and prevent the transmission of infections within hospital settings.

The effort has been led by Drs. Alex Sundermann and Lee Harrison, both esteemed members of the Scientific Advisory Board at Next Gen Diagnostics (NGD) Infection Prevention. This recognition signifies a major achievement not only for the hospital but also for the infection control community at large, highlighting the importance of innovation and proactive measures in patient safety.

Dr. Paul Rhodes, the founder and CEO of NGD, emphasized how this recognition underscores the critical role of prospective bacterial WGS in identifying potential infection transmission before it escalates into widespread outbreaks. Traditional methods of infection surveillance often fall short in detecting transmission events; however, the use of WGS allows healthcare teams to intervene swiftly, thereby safeguarding patients and reducing hospital stays. Recent reports indicate that UPMC Presbyterian's application of WGS not only improved patient safety but also resulted in significant cost savings, far exceeding the service's operational costs.

The Joint Commission's acknowledgment of UPMC Presbyterian serves as a compelling endorsement of the approach taken by the hospital. It provides significant credibility to the growing interest among healthcare facilities in adopting advanced genomic techniques as integral components of their infection prevention strategies. As hospitals grapple with increasing infection rates, the strategic implementation of genomic surveillance stands as a beacon of hope in combating these challenges.

The NGD200 system, developed by NGD Infection Prevention, offers a fully automated solution for genomic sequencing, capable of preparing up to 48 samples with minimal hands-on time. It integrates cloud bioinformatics, enabling thorough quality control and analysis overnight, ensuring timely and actionable insights for infection control practitioners. One of the highlights of the system is EpiAssist, a feature designed to streamline the identification of the root cause of infection transmission, allowing healthcare workers to focus on implementing effective interventions.

With a laboratory strategically located in Cambridge, Massachusetts, and a subsidiary in Israel, NGD Infection Prevention operates at the forefront of technological advancement in genomic solutions for healthcare. As the healthcare sector evolves, the integration of WGS for infection prevention is positioned to play a pivotal role in improving patient care and mitigating risks associated with hospital-acquired infections (HAIs).

In summation, the recognition of UPMC Presbyterian Hospital by the Joint Commission not only celebrated the innovative use of genomic surveillance but also reinforced a shift toward more proactive, data-driven strategies in infection control. As healthcare institutions continue to prioritize patient safety, the success story of UPMC Presbyterian is a powerful reminder of what can be achieved through innovation, collaboration, and a commitment to excellence in care delivery.